Pharma/Biotech Update: CSL Behring Submits New Drug to FDA
According to a recent news article released by the website MPR, CSL Behring is officially submitting a Biologistics License Application…
Posts by tag: inhibitors
Europe: New Hemophilia A Medication Granted Orphan Status
An article from Clinical Leader today announced that the pharmaceutical company, Apitope, was recently granted orphan drug status for its…
Novo Nordisk Introduces HERO Program
Hot off the presses. According to a release from MarketWatch, Novo Nordisk announced the launch of the HeroPath™ Life Coach…
Octapharma’s Hemophilia A Drug Approved By European Commission
Another hemophilia option will soon be available to the masses in Europe. According to the website Pharmaceutical Processing, the European…
No More Hemophilia Inhibitors?
For those who suffer from the chronic bleeding disorder hemophilia and antibodies caused by it’s medication (clotting factor), new research…
NovoSeven Approved for Rare Bleeding Disorder
A release via Zacks.com announced that Novo Nordisk received the United States Food and Drug Administration (FDA) approval for treatment of…
Will People Switch Their Factor Medication?
Biogen Idec currently has two products on the market – Alprolix for hemophilia B and Eloctate for hemophilia A. A…
Pharma/Biotech Update: Eloctate Meets Objectives in Hemophilia A Study
A recent article written by Michael Calia at NASDAQ shows promise for Biogen Idec’s up and coming hemophilia A (factor VIII deficiency)…
FLORIDA – HEMOPHILIA FEDERATION OF AMERICA ANNUAL SYMPOSIUM
Who: Hemophilia Federation of America (HFA) What: HFA Annual Symposium Where: Tampa, Florida When: March 27 – 29, 2014 Click…
NEW HEMOPHILIA INHIBITOR DRUG REACHES PHASE 3
People who have encountered an inhibitor in their lifetime know how damaging it can be to the human body. With…